Brazil Crocin Market Size & Outlook, 2023-2030
Brazil crocin market, 2018-2030 (US$M)
Related Markets
Brazil crocin market highlights
- The Brazil crocin market generated a revenue of USD 125.0 million in 2023 and is expected to reach USD 179.0 million by 2030.
- The Brazil market is expected to grow at a CAGR of 5.3% from 2024 to 2030.
- In terms of segment, purity>98% was the largest revenue generating purity in 2023.
- Purity>98% is the most lucrative purity segment registering the fastest growth during the forecast period.
Crocin market data book summary
| Market revenue in 2023 | USD 125.0 million |
| Market revenue in 2030 | USD 179.0 million |
| Growth rate | 5.3% (CAGR from 2023 to 2030) |
| Largest segment | Purity>98% |
| Fastest growing segment | Purity>98% |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Purity>98%, Purity<98% |
| Key market players worldwide | Merck KGaA, GSK PLC, Cipla Ltd DR, Novartis AG ADR, Sanofi SA, Aurobindo Pharma, Teva Pharmaceutical Industries Ltd, Mallinckrodt PLC Ordinary Shares - New, Cayman Chemical, Tokyo Chemical Industry, APExBIO Technology, Wilshire Technologies, Biosynth |
Other key industry trends
- In terms of revenue, Brazil accounted for 2.6% of the global crocin market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil crocin market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in Latin America and is projected to reach USD 95.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Crocin Market Scope
Crocin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil crocin market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to crocin market will help companies and investors design strategic landscapes.
Purity>98% was the largest segment with a revenue share of 95.52% in 2023. Horizon Databook has segmented the Brazil crocin market based on purity>98%, purity<98% covering the revenue growth of each sub-segment from 2018 to 2030.
Pain medications are among the most commonly consumed medications in Brazil, with analgesic action agents tend to be used for self-medication by people in Brazil. Moreover, the government has been focusing on improving the access to pain relief to offer points of comparison in the Central and South American regions.
Diclofenac (10.7%), Metamizole (37.8%), and paracetamol (25.3%) are the most commonly used drugs in Brazil. These medications were primarily used to treat minor health issues, especially pain. Domestic pharmaceutical companies play a major role in the Brazil pharmaceutical market and hold a high rank in the list of producers.
This includes companies such as Aché Laboratórios Farmacêuticos S.A., EMS Pharma, Eurofarma, and Neo Química. Moreover, international companies are increasing investment in Brazil to increase the production of pharmaceutical products, which can be attributed to the higher return on investment compared to the developed economies.
Reasons to subscribe to Brazil crocin market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil crocin market databook
-
Our clientele includes a mix of crocin market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil crocin market , including forecasts for subscribers. This country databook contains high-level insights into Brazil crocin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil crocin market size, by purity, 2018-2030 (US$M)
Brazil Crocin Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
